Leveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease
Circulation Research · 2026
DOI: 10.1161/circresaha.125.326002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, 2026. Verfasst von Robert S Gardner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmacology and Medicine, The State University of New York Upstate Medical University, Syracuse, NY (R.S.G., N.R.T.). Hauptthemen laut MEDLINE: Single-Cell Analysis, Myocardium, Cardiomyopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Advances in single-cell genomics and transcriptomics have transformed our understanding of human disease by uncovering previously masked cellular heterogeneity and therapeutic targets. Yet, adoption of these technologies in cardiovascular disease has lagged behind in large part due to technical and logistical challenges, but advances in tissue procurement and molecular approaches have brought the human heart firmly into the single-cell era. With an increasing number of studies addressing human myocardium, substantial insights have been elucidated into myocardial cellular composition and molecular heterogeneity in health and disease, and cell-specific contributions to cardiovascular disease. In this review, we provide an overview of the rapidly expanding body of single-cell and single-nuclear studies that interrogate the human myocardium, highlighting how these platforms are redefining our understanding of cardiovascular disease. Specifically, we provide a snapshot of major experimental and computational approaches within the single-cell space, prioritize the impact of these technologies in human cardiovascular disease, and describe a roadmap to how insights gained from these approaches may accelerate their translation from bench to bedside application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Pharmacology and Medicine, The State University of New York Upstate Medical University, Syracuse, NY (R.S.G., N.R.T.).
- Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (K.A.).
ORCID-Profile: Robert S Gardner, Nathan R Tucker, Kaushik Amancherla
Förderung
- NHLBI NIH HHS
Zitieren
APA
Gardner, R. S., Tucker, N. R., & Amancherla, K. (2026). Leveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease. Circulation Research. https://doi.org/10.1161/circresaha.125.326002
Vancouver
Gardner RS, Tucker NR, Amancherla K. Leveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease. Circulation Research. 2026. doi:10.1161/circresaha.125.326002
BibTeX
@article{Gardner2026,
author = {Gardner, Robert S and Tucker, Nathan R and Amancherla, Kaushik},
title = {Leveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease},
journal = {Circulation Research},
year = {2026},
doi = {10.1161/circresaha.125.326002}
}
EUVIMED